BackOnconova Therapeutics Overview

Onconova Therapeutics Accounts Payable

Latest accounts payable for ONTX: $7.7M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$7.67M
↑ 61.06% YoYΔ $2.91M vs prior year quarter

Peer trimmed avg / median

Loading

Onconova Therapeutics Accounts Payable History

Loading

Onconova Therapeutics vs. peers: Accounts Payable Comparison

Loading

Onconova Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Onconova Therapeutics (ONTX) FAQ

Onconova Therapeutics (ONTX) currently reports a accounts payable of $7.7M as of June 2026. That compares with $4.8M in the prior-year period — up 61.1% year over year. Use the charts on this page to explore Onconova Therapeutics's accounts payable history and peer comparisons.

Onconova Therapeutics's accounts payable increased from $4.8M to $7.7M — a 61.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Onconova Therapeutics reported $7.7M in accounts payable as of June 2026. That compares with $4.8M in the prior-year period — up 61.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $7.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Onconova Therapeutics, and consider following ONTX for alerts when major investors trade the stock.

Onconova Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $7.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONTX with unrelated industries.